Extrapolating Clinical Evidence Within Economic Evaluations
Canadian Journal of Health Technologies · 15.05.2023 · 3 (5)
DOI: 10.51731/cjht.2023.649 ↗Kurz gefasst
Fachartikel in der Zeitschrift Canadian Journal of Health Technologies, online erschienen am 15.05.2023. Verfasst von Doug Coyle und 2 weiteren Autor:innen. Die Arbeit wurde bisher 9-mal zitiert (Crossref).
Abstract (Originalsprache)
Extrapolation is a fundamental part of many economic evaluations, though there are numerous methods of extrapolating the same dataset. The method that is most appropriate for the decision problem is contingent on several factors. From the literature, recommendations for best practices when it comes to the extrapolation of clinical data have been identified. These pertain to validation of output, use of external evidence, treatment waning, proportional hazards, characterization of uncertainty, reporting of results, and choice of decision model. Gaps remain in the literature that require further research regarding what is the minimum amount of data to extrapolate reliably and how to robustly extrapolate relative effects for multiple treatment comparisons.
Zitieren
APA
Coyle, D., Haines, A., & Lee, K. (2023). Extrapolating Clinical Evidence Within Economic Evaluations. Canadian Journal of Health Technologies, 3(5). https://doi.org/10.51731/cjht.2023.649
Vancouver
Coyle D, Haines A, Lee K. Extrapolating Clinical Evidence Within Economic Evaluations. Canadian Journal of Health Technologies. 2023;3(5). doi:10.51731/cjht.2023.649
BibTeX
@article{Coyle2023,
author = {Coyle, Doug and Haines, Alex and Lee, Karen},
title = {Extrapolating Clinical Evidence Within Economic Evaluations},
journal = {Canadian Journal of Health Technologies},
year = {2023},
volume = {3},
number = {5},
doi = {10.51731/cjht.2023.649}
}
EUVIMED